Getting Ozempic prescribed starts with a diagnosis of type 2 diabetes. Ozempic is FDA-approved specifically for managing blood sugar in adults with type 2 diabetes, not for weight loss on its own, so your path to a prescription depends on meeting that core requirement. The process involves a doctor’s visit, blood work confirming your diagnosis, and often a round of insurance paperwork before you fill your first pen.
What Ozempic Is Actually Approved For
Ozempic (semaglutide) has three FDA-approved uses, all tied to type 2 diabetes. It’s approved as an add-on to diet and exercise to lower blood sugar in adults with type 2 diabetes, to reduce the risk of heart attack, stroke, and cardiovascular death in adults with type 2 diabetes who also have heart disease, and to slow kidney disease progression in adults with type 2 diabetes and chronic kidney disease. It is not approved for children, and it is not approved for weight loss.
This matters because if your primary goal is losing weight rather than controlling blood sugar, the FDA-approved option is Wegovy, which contains the same active ingredient but at a higher maximum dose (2.4 mg weekly versus Ozempic’s 2 mg). Your doctor may still prescribe Ozempic off-label for weight management, but insurance is far less likely to cover it without a type 2 diabetes diagnosis.
The Medical Criteria You Need to Meet
To prescribe Ozempic, your doctor needs evidence that you have type 2 diabetes. In practice, this means at least one of the following: an A1C of 6.5% or higher, a fasting blood sugar of 126 mg/dL or above, a two-hour glucose tolerance test result of 200 mg/dL or above, or symptoms of high blood sugar (excessive thirst, frequent urination, unexplained hunger) combined with a random blood sugar reading of 200 mg/dL or higher.
Your doctor will also screen for conditions that rule out Ozempic entirely. You cannot take it if you or a close family member has a history of medullary thyroid carcinoma or a condition called Multiple Endocrine Neoplasia syndrome type 2. A previous allergic reaction to semaglutide also disqualifies you. Beyond those hard stops, your doctor will consider your full medication list to make sure you’re not already on another drug in the same class (GLP-1 receptor agonists), since doubling up isn’t allowed.
What the Appointment Looks Like
You can get an Ozempic prescription through your primary care doctor, an endocrinologist, or a telehealth platform. The visit typically involves reviewing your medical history, current medications, and any allergies. If you don’t already have recent blood work showing your A1C or fasting glucose, your provider will order labs before writing a prescription. Some telehealth services let you upload existing lab results to speed things up.
Once your provider confirms you meet the criteria, they’ll start you on the lowest dose (0.25 mg weekly for the first four weeks) and gradually increase it. This slow ramp-up is standard and helps minimize nausea and other digestive side effects. Expect follow-up appointments to check whether your blood sugar is improving and to adjust your dose.
Getting Through Insurance Approval
Most insurance plans require prior authorization before they’ll cover Ozempic. This means your doctor’s office submits documentation proving you have type 2 diabetes and meet the plan’s clinical criteria. A representative example from CVS Caremark’s federal plan shows what insurers typically ask for: lab results confirming your diabetes diagnosis, confirmation you’re not on another GLP-1 medication, and for renewals, evidence that your blood sugar has improved or stabilized on the drug.
Quantity limits are common. That same plan caps Ozempic at three pens per 84 days. If your prior authorization is denied, your doctor can file an appeal or switch you to a different medication in the same class that your plan prefers. This “step therapy” requirement, where your insurer wants you to try a cheaper drug first, is one of the most common reasons for initial denials.
What It Costs Out of Pocket
If you have commercial insurance and your plan covers Ozempic, the manufacturer offers a savings card that can reduce your copay. Eligibility details and specific savings amounts are available through NovoCare.
If you’re uninsured or paying cash, Novo Nordisk currently offers an introductory price of $199 per month for the lower doses (0.25 mg and 0.5 mg), available for the first two monthly fills. After that, the price jumps to $349 per month for doses up to 1 mg, and $499 per month for the 2 mg dose. These are significant ongoing costs, so it’s worth confirming your insurance situation before starting treatment.
Why Ozempic and Wegovy Are Not Interchangeable
Both Ozempic and Wegovy contain semaglutide, but they’re approved for different conditions and come in different dose ranges. Wegovy tops out at 2.4 mg per week and is approved for weight management in adults and children 12 and older with obesity or overweight plus a weight-related health condition. Ozempic maxes out at 2 mg and is approved only for type 2 diabetes.
If you’re asking about Ozempic specifically because you want help with weight loss, your doctor may recommend Wegovy instead. Insurance coverage, availability, and your specific health profile will all factor into which one makes more sense. Some providers prescribe Ozempic off-label for weight, but you’re more likely to hit insurance roadblocks without a diabetes diagnosis on file.
Be Cautious With Compounded Versions
During Ozempic’s shortage period from 2022 through early 2025, compounding pharmacies filled the gap by making their own semaglutide products. That shortage has since been resolved, and the FDA has tightened its stance on compounded versions now that the brand-name drug is available.
The risks with compounded semaglutide are real. The FDA has received reports of hospitalizations tied to dosing errors, with patients accidentally injecting five to 20 times more than their intended dose. This happened because compounded products come in vials with varying concentrations, and instructions sometimes list doses in “units” rather than milligrams, making it easy to miscalculate. Reported adverse events included severe nausea, vomiting, fainting, dehydration, acute pancreatitis, and gallstones.
There are additional concerns beyond dosing. Some compounders have used salt forms of semaglutide (such as semaglutide sodium or semaglutide acetate) rather than the base form used in the approved drug. The FDA has said it’s not aware of any legal basis for using these salt forms in compounding. Other compounders add ingredients like vitamin B-12, L-carnitine, or NAD to their formulations, combinations that have never been tested for safety or effectiveness. Compounded drugs skip the FDA’s premarket review process entirely, so there’s no independent check on quality, potency, or sterility before they reach you.